Neoleukin Therapeutics, Inc.
Q4 2019 13F Holders
Symbol
NLTX
CUSIP
64049K104
Type
Equity
Class
COM
Num filings
60
Total reported value, excl. options
$245 M
Compare 2019 Q4 to
2023 Q2
2023 Q1
2022 Q4
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q3
Manager
Report Date
Value ($000)
Shares
Option Type